Tal Freund

561 total citations
13 papers, 299 citations indexed

About

Tal Freund is a scholar working on Immunology, Infectious Diseases and Oncology. According to data from OpenAlex, Tal Freund has authored 13 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Infectious Diseases and 3 papers in Oncology. Recurrent topics in Tal Freund's work include SARS-CoV-2 and COVID-19 Research (7 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and COVID-19 Clinical Research Studies (4 papers). Tal Freund is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Immunodeficiency and Autoimmune Disorders (4 papers) and COVID-19 Clinical Research Studies (4 papers). Tal Freund collaborates with scholars based in Israel and United States. Tal Freund's co-authors include David Hagin, Tami Halperin, Inbar Levi, Natalia T. Freund, Yifat Alcalay, Shira Benor, Yael Bar‐On, Odelia Amit, Sigi Kay and Ron Ram and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Human Genetics.

In The Last Decade

Tal Freund

13 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tal Freund Israel 7 213 126 89 37 36 13 299
Inbar Levi Israel 4 120 0.6× 179 1.4× 57 0.6× 18 0.5× 20 0.6× 5 258
Margaret Lamb United States 6 110 0.5× 111 0.9× 130 1.5× 18 0.5× 10 0.3× 11 271
Line Dam Heftdal Denmark 10 88 0.4× 105 0.8× 56 0.6× 10 0.3× 24 0.7× 17 263
Lohith Gowda United States 11 178 0.8× 67 0.5× 186 2.1× 21 0.6× 12 0.3× 35 439
Marianne Graninger Austria 7 237 1.1× 45 0.4× 24 0.3× 14 0.4× 9 0.3× 16 277
Giulia Baresi Italy 4 207 1.0× 91 0.7× 19 0.2× 19 0.5× 7 0.2× 4 269
Tina Thomson United Kingdom 7 213 1.0× 51 0.4× 40 0.4× 50 1.4× 29 0.8× 10 319
Simon Eschweiler United Kingdom 4 257 1.2× 192 1.5× 85 1.0× 12 0.3× 10 0.3× 5 449
Amandine Le Bourgeois France 12 130 0.6× 161 1.3× 166 1.9× 16 0.4× 15 0.4× 62 437
Rabah Redjoul France 11 125 0.6× 69 0.5× 78 0.9× 9 0.2× 10 0.3× 26 309

Countries citing papers authored by Tal Freund

Since Specialization
Citations

This map shows the geographic impact of Tal Freund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Freund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Freund more than expected).

Fields of papers citing papers by Tal Freund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Freund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Freund. The network helps show where Tal Freund may publish in the future.

Co-authorship network of co-authors of Tal Freund

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Freund. A scholar is included among the top collaborators of Tal Freund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Freund. Tal Freund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Eviatar, Tali, et al.. (2024). Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls. Clinical & Experimental Immunology. 217(2). 167–172. 1 indexed citations
2.
3.
Ram, Ron, Tal Freund, Tami Halperin, et al.. (2022). Immunogenicity of a Third Dose of the BNT162b2 mRNA Covid-19 Vaccine in Patients with Impaired B Cell Reconstitution After Cellular Therapy—A Single Center Prospective Cohort Study. Transplantation and Cellular Therapy. 28(5). 278.e1–278.e4. 7 indexed citations
4.
Shamriz, Oded, Limor Rubin, Anthony Simon, et al.. (2022). Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience. Frontiers in Immunology. 13. 1044933–1044933. 4 indexed citations
5.
Grupper, Ayelet, Liane Rabinowich, Merav Ben‐Yehoyada, et al.. (2022). Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients. Transplantation Proceedings. 54(6). 1439–1445. 7 indexed citations
6.
Freund, Tal, Sarah K. Baxter, Tom Walsh, et al.. (2022). Clinically Complex LRBA Deficiency Due to a Founder Allele in the Georgian Jewish Population. Journal of Clinical Immunology. 43(1). 151–164. 1 indexed citations
7.
Kurolap, Alina, David Hagin, Tal Freund, et al.. (2022). CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a−) variant. Human Genetics. 142(5). 683–690. 5 indexed citations
8.
Turner, Dan, Amos Adler, Inbar Levi, et al.. (2022). SARS-CoV-2 Humoral and Cellular Immune Responses of Patients With HIV After Vaccination With BNT162b2 mRNA COVID-19 Vaccine in the Tel-Aviv Medical Center. Open Forum Infectious Diseases. 9(4). ofac089–ofac089. 19 indexed citations
9.
Ram, Ron, David Hagin, Tal Freund, et al.. (2021). Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study. Transplantation and Cellular Therapy. 27(9). 788–794. 94 indexed citations
10.
Hagin, David, Tal Freund, Tami Halperin, et al.. (2021). Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity. Journal of Allergy and Clinical Immunology. 148(3). 739–749. 116 indexed citations
11.
Luttwak, Efrat, David Hagin, Chava Perry, et al.. (2020). Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series. Bone Marrow Transplantation. 56(5). 1031–1037. 27 indexed citations
12.
Chermesh, Irit, Lael Werner, Ortal Barel, et al.. (2020). Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a Diagnosis. Frontiers in Immunology. 11. 1775–1775. 6 indexed citations
13.
Lachover‐Roth, Idit, Pazit Salamon, Tal Freund, et al.. (2020). Novel NCF2 Mutation Causing Chronic Granulomatous Disease. Journal of Clinical Immunology. 40(7). 977–986. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inbar Levi Breakdown of academic impact, for papers by Margaret Lamb Breakdown of academic impact, for papers by Line Dam Heftdal Breakdown of academic impact, for papers by Lohith Gowda Breakdown of academic impact, for papers by Marianne Graninger Breakdown of academic impact, for papers by Giulia Baresi Breakdown of academic impact, for papers by Tina Thomson Breakdown of academic impact, for papers by Simon Eschweiler Breakdown of academic impact, for papers by Amandine Le Bourgeois Breakdown of academic impact, for papers by Rabah Redjoul
Rankless by CCL
2026